Alternatively, we could hypothesize that the decrease in Tau function could participate in the brain neuroinflammation observed in AD models and that this phenomena could favor glioma growth (Sanchez-Valle et al., 2017; Laurent et al., 2018). Here, MAPT is linked to Alzheimer disease.